Human Longevity Drops a $599 Clinical-Grade Genome
Less than two weeks after the death of its co-founder Dr. J. Craig Venter on April 29, 2026, Human Longevity, Inc. (HLI) has launched a...
Machine learning applied to scientific work, from foundation models for biology to AI agents that run experiments.
56 articles
Less than two weeks after the death of its co-founder Dr. J. Craig Venter on April 29, 2026, Human Longevity, Inc. (HLI) has launched a...
In a study published last month in Science, a team led by Harris H. Wang at Columbia University, with collaborators at MIT and Harvard, used...
OpenAI has officially unveiled GPT-Rosalind — its first frontier reasoning model purpose-built for biology, drug discovery, and translational medicine. Named after the British chemist Rosalind...
Drug discovery has two big machine learning stories: The first — de novo design, where AI conjures entirely new protein binders from scratch — has...
Amazon Web Services (AWS) today introduced BioDiscovery, a platform designed to unify biological data processing, AI model development, and scalable experimentation workflows within a single...
The race to reinvent drug discovery is accelerating—and Medra.ai is quickly emerging as a key player. Following a $52 million funding round, the company is...
A new pipeline marries de novo protein design with robotic sample prep and NMR spectroscopy — producing atomic-resolution data at a pace that was unthinkable...
Chem-Impex launches a 6-week fellowship for early-career peptide researchers — offering mentorship, visibility, and a chance to advance their science.